Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tenax Therapeutics Inc shares valued at $12,500 were purchased by Giordano Christopher Thomas on Nov 18 ’25. At $7.75 per share, Giordano Christopher Thomas acquired 1,612 shares. The insider’s holdings grew to 1,612 shares worth approximately $15265.640000000001 following the completion of this transaction.
Also, Giordano Christopher Thomas purchased 538 shares, netting a total of over 4,083 in proceeds. Following the buying of shares at $7.59 each, the insider now holds 2,605 shares.
Before that, Giordano Christopher Thomas had added 455 shares to its account. In a trade valued at $3,417, the CEO bought Tenax Therapeutics Inc shares for $7.51 each. Upon closing the transaction, the insider’s holdings increased to 455 shares, worth approximately $19574.49.
As published in their initiating research note from Piper Sandler on September 08, 2025, Tenax Therapeutics Inc [TENX] has been an Overweight and the price target has been revised to $20. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in late October. As of October 14, 2024, Guggenheim has initiated its “Buy” rating for TENX. Earlier on September 30, 2024, William Blair initiated its rating. Their recommendation was “an Outperform” for TENX stock.
Analyzing TENX Stock Performance
On last trading session, Tenax Therapeutics Inc [NASDAQ: TENX] rose 0.74% to $9.47. The stock’s lowest price that day was $9.0926, but it reached a high of $9.7 in the same session. During the last five days, there has been a surge of approximately 29.37%. Over the course of the year, Tenax Therapeutics Inc shares have jumped approximately 92.48%. Shares of the company reached a 52-week high of $9.70 on 11/26/25 and a 52-week low of $4.63 on 04/22/25.
Support And Resistance Levels for Tenax Therapeutics Inc (TENX)
According to the 24-hour chart, there is a support level at 9.14, which, if violated, would cause prices to drop to 8.81. In the upper region, resistance lies at 9.75. The next price resistance is at 10.03. RSI (Relative Strength Index) is 76.49 on the 14-day chart, showing overbought technical sentiment.
Is Tenax Therapeutics Inc subject to short interest?
Stocks of Tenax Therapeutics Inc saw a sharp rise in short interest on 2025-11-14 jumping by 3902.0 shares to 0.76 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 0.75 million shares. A jump of 0.51% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 11.07 of the overall float, the days-to-cover ratio (short ratio) jumped to 11.07.
Which companies own the most shares of Tenax Therapeutics Inc (TENX)?
In terms of Tenax Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 112.77% from the previous closing price of $9.4. Analysts anticipate Tenax Therapeutics Inc stock to reach 20 by 2025, with the lowest price target being 20.
